.svg){kind=small}
May-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
In May 2026, The Tablet operated as a single-category brand with Capsules at 100.0% of mix, pairing 34.999% year-over-year growth with a 33.230% month-over-month lift; the concurrent 19.263% YoY decline in average price to $32.43 indicates volume-led expansion rather than ticket-driven gains. Within Capsules, the brand held rank 7 in California, suggesting mid-pack scale while growing faster MoM than the typical seasonal baseline; the combination of 100.0% category concentration and a 34.999% YoY gain implies a focused bet on Capsules that is currently paying off in units despite price compression.
The price contraction of 19.263% alongside a 33.230% MoM surge and rank 7 in California implies that The Tablet is leveraging price elasticity to win trial and repeat in Capsules, trading margin for share velocity; given 100.0% reliance on Capsules and a 34.999% YoY upswing, the positioning skews toward scale-through-accessibility rather than premium scarcity. With Capsules as the sole growth engine and a mid-tier rank, the pattern implies that short-term share capture is feasible if the brand sustains sub-$35 pricing, but long-term differentiation will hinge on whether unit gains persist as promotional intensity normalizes.
Competitive Landscape
The Tablet sits at #7 in CA Capsules in May 2026, improving 1 rank position YoY from #8, while holding steady versus three months ago at #8 to #7 suggests only a modest upward drift; meanwhile, Breez moved from #2 to #1 as its sales fell 44.6% YoY and Level slipped from #1 to #2 with a 67.8% YoY sales decline, indicating leadership churn that The Tablet has not capitalized on despite achieving a peak rank of #7 in May 2026. With Buddies climbing from #6 to #4 alongside an 18.6% YoY sales decline and Kikoko dropping from #4 to #5 with a 39.8% YoY decline, the competitive set is reshuffling around The Tablet, implying its incremental rank gain positions it to benefit from volatility but not yet to break into the top 5 without a sharper share shift.
Notable Products
Indica High Dose Tablets 50-Pack (1000mg) posted the largest month-over-month surge at 51.8%, moving into rank 2 while Sativa High Dose Tablets 50-Pack (1000mg) rose 45.6% to hold rank 1. In parallel, Sativa Tablets 20-Pack (1000mg) advanced 14.1% at rank 3 and Indica Tablets 20-Pack (1000mg) increased 19.0% at rank 4, and all four top-10 SKUs are Capsules, concentrating the lineup in one format. With $60,730 concentrated in the top-ranked SKU alongside a second SKU growing over 50%, the mix tilts toward higher-dose, high-count packs that favor volume consolidation in premium-strength Capsules.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
